Pelleting process of combined traditional Chinese medicine pills

The supercritical CO2 method is used to form liposome medicine liquid and combined with jet embedding treatment, which solves the problems of inefficiency and lack of embedding layer in the pill making process of Chinese medicine, and realizes the full release and absorption of Chinese medicine ingredients in the small intestine, improving the efficacy of the medicine.

CN120000604AInactive Publication Date: 2025-05-16JILIN JUNHONG PHARM CO LTD
View PDF 9 Cites 0 Cited by

Patent Information

Application Number
CN202510488180.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-04-18
Publication Date
2025-05-16
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing Chinese pill making process is inefficient, uneven quality, and lack of an embedded layer, resulting in the inability to fully release the efficacy under the influence of gastric digestion.

Method used

The supercritical CO2 method is used to treat soybean phospholipids and mixed slurries to form liposomal liquids, and the drug components are embedded using enteric materials through jet embedding to ensure that the drug is fully released in the small intestine.

Benefits of technology

It improves the absorption of Chinese medicine ingredients in the human body, avoids the influence of gastric digestion, and achieves better performance of the medicine.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120000604A_ABST
    Figure CN120000604A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of combined traditional Chinese medicine preparation, and discloses a pill making process of combined traditional Chinese medicine pills. The pelleting process comprises the following steps: S1, preparing traditional Chinese medicinal materials; s2, treating the traditional Chinese medicinal materials; s3, obtaining mixed medicine slurry; s4, obtaining a liposome liquid medicine; s5, filtering the lipidosome liquid medicine, and retaining lipidosome particles; s6, drying to obtain powdery auxiliary materials; s7, mixing 2 / 3 of the powdery auxiliary material with the liposome particles, adding talcum powder, an excipient and a disintegrating agent, and stirring and mixing to obtain a wet medicine block; s8, putting the wet medicine blocks into pelleting equipment, and then adding residual powdery auxiliary materials for pelleting treatment; and S9, spraying and embedding to obtain a traditional Chinese medicine pill product. The pill preparation effect is excellent, the traditional Chinese medicine pill product which is not influenced by stomach digestion, can be fully released in the small intestine and can better exert the medicine effect can be prepared, and the absorbance of the traditional Chinese medicine ingredients in the human body is high.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of combined Chinese medicine preparation, in particular to a pill-making process of combined Chinese medicine pills. Background Art

[0002] Combined Chinese medicine pills are modern Chinese medicines based on the theory of traditional Chinese medicine and follow the compatibility theory and principles of Chinese medicine prescriptions. They are composed of effective components or effective parts. Among them, the various medicinal ingredients in the combined Chinese medicine pills are extracted, concentrated and refined, and then formed through a pill-making process. The Chinese medicine pills obtained by the above production are in granular form. Compared with Chinese medicine liquid, Chinese medicine pills are easier to swallow. Therefore, Chinese medicine pills have become the mainstream product of current Chinese medicine health care.

[0003] The invention patent with reference number CN111529595A discloses a Chinese medicine combination health-care pill and a preparation method thereof, which adopts the method of first boiling the medicinal materials into a viscous mixed ointment, then kneading them into a ball manually, and then manually trimming them to make the Chinese medicine pills. There are problems of low efficiency and uneven quality. In addition, the pills prepared by the aforementioned patent scheme do not have an embedding layer, so that they will be affected by gastric digestion after taking them, affecting the efficacy of the medicine. Summary of the invention

[0004] In view of the above-mentioned shortcomings of the prior art, the purpose of the present invention is to provide a process for making a combined Chinese medicine pill to produce a Chinese medicine pill product that is not affected by gastric digestion, can achieve full release in the small intestine and better exerts its efficacy.

[0005] The process for making the combined Chinese medicine pills comprises the following steps: S1 Prepare Chinese medicinal materials according to prescriptions; S2 processes Chinese medicinal materials; After the Chinese medicinal materials treated in S3 are boiled at high temperature, they are further concentrated and purified to obtain a mixed medicinal slurry; S4 processes soybean lecithin and mixed drug slurry based on supercritical CO2 method to obtain liposome drug solution; S5 filters the liposome solution and retains the liposome particles; S6: Boil the seeded hawthorn and honey, dry them to obtain a powdered auxiliary material, and set aside; S7: 2 / 3 of the powdered excipients and liposome particles are mixed, and then talcum powder, excipients and disintegrants are added, and the mixture is stirred to obtain a wet drug block; S8 takes the wet medicine block and puts it into the pill making equipment, and then adds the remaining powdered auxiliary materials to make pills; S9 performs jet embedding treatment on the pills obtained through the pill making treatment to obtain Chinese medicine pill products.

[0006] As a further improvement of the above scheme, the Chinese medicinal materials are at least eight of angelica, wolfberry, rhubarb, astragalus, ginseng, asarum, schisandra, codonopsis, rehmannia, Achyranthes bidentata, yam, white peony root, atractylodes, cornus officinalis, gardenia, julibrissin bark, mint and wolfberry.

[0007] As a further improvement of the above scheme, the method for processing Chinese medicinal materials is specifically operated as follows: removing soil impurities and non-medicinal parts of the Chinese medicinal materials, washing and drying the Chinese medicinal materials, and then crushing the Chinese medicinal materials to obtain Chinese medicinal materials. The present invention is based on the crushing process to facilitate the full extraction of effective medicinal components during subsequent high-temperature cooking.

[0008] As a further improvement of the above scheme, the high-temperature cooking is carried out in a reactor, and the temperature of the reactor is 80-100° C., and the cooking time is 6-12 hours.

[0009] As a further improvement of the above scheme, the method of concentration and purification is specifically operated as follows: the boiled medicinal liquid and the medicinal residue are transferred to a concentrator for concentration and purification 2 to 5 times, and then the medicinal liquid is filtered to retain the medicinal residue, and the medicinal residue is discarded. The concentration and purification adopts any one of water decoction, immersion, percolation, modified gelatin method, reflux method, solvent extraction, steam distillation and sublimation.

[0010] As a further improvement of the above scheme, the method for obtaining the liposome drug solution is specifically performed as follows: S41 Take soybean lecithin and mixed medicine slurry in a ratio of 7:1, mix and grind; S42 was added three times, 10 mL of 0.2 mol / L PBS phosphate buffer solution with a pH of 6.0 was added each time, and the mixture was further ground evenly, and then transferred to an autoclave; S43: At a shear rate of 3000 r / min and a temperature of 45°C, supercritical CO2 was introduced into the autoclave until the set pressure was reached, and then ultrasound was turned on with an ultrasound power of 18 W. The ultrasound and shearing treatment was maintained for 50 min, and the heating, shearing and ultrasound were stopped in sequence, and CO2 was released; S44 added 100 mL of PBS phosphate buffer solution to rinse the particles on the inner wall of the autoclave, and treated with ultrasound and stirring for 40 minutes to obtain a liposome drug solution.

[0011] As a further improvement of the above scheme, the seeded hawthorn and honey are boiled and placed in a drying device, dried at a temperature of 90-100° C. for 20-30 minutes, and the solid dry product is taken out and transferred to a grinder for grinding and crushing to obtain a powdered auxiliary material.

[0012] As a further improvement of the above scheme, the talcum powder accounts for 0.5% to 1.5% of the total amount of liposome particles, the excipient accounts for 6% to 12% of the total amount of liposome particles, and the disintegrant accounts for 2% to 4% of the total amount of liposome particles. In the present invention, talcum powder is added as an intermediate sand body, so that in the subsequent drying process, the medicine is evenly heated, and the modification of the drug components caused by uneven heat distribution is prevented, and the drying quality is improved. The added disintegrant promotes the disintegration and release of the Chinese medicine components in the pills after entering the human body, so that the drug properties are quickly dispersed, and the added excipients induce the viscosity of the drug components to facilitate the pill molding.

[0013] As a further improvement of the above scheme, the disintegrant is CMC or HPMC, which is used to promote the disintegration and release of the traditional Chinese medicine pills after entering the human body; the excipient includes a wetting agent and a binder; wherein the wetting agent is water, wine, vinegar or medicinal juice, and the binder is rice paste, flour paste or medicinal material paste.

[0014] As a further improvement of the above scheme, the method of spray embedding treatment is specifically performed as follows: S91: taking an enteric material and water in a volume ratio of 1:1, heating and ultrasonically stirring to obtain a solution; The S92 solution is loaded into the spraying device, and the size, speed and morphology of the piezoelectric nozzle droplets are controlled according to the preset parameters. The solution is evenly sprayed on the pills obtained through the pill making process, and then dried and polished to obtain the Chinese medicine pill products.

[0015] As a further improvement of the above scheme, the enteric material is any one of cellulose acetate phthalate, hydroxypropyl methylcellulose phthalate, polyvinyl phthalate and acrylic resin.

[0016] As a further improvement of the above scheme, the pill making equipment includes a shell, a wet medicine block inlet hopper fixedly installed through the center position of the top of the shell, a rotating assembly rotatably installed in the shell, a screen fixedly installed at the discharge port position of the shell, a heating layer fixedly installed in the shell, and a powder sprinkling structure fixedly installed at the top surface position of the wet medicine block inlet hopper.

[0017] As a further improvement of the above solution, the powder sprinkling structure includes a bracket, a powder holding tube slidably installed at the center of the bracket, and a pressure plate fixedly sleeved on the powder holding tube.

[0018] As a further improvement of the above solution, the rotating assembly includes two groups of motors fixedly installed at the front surface of the shell and a pill-making roller fixedly connected to the output end positions of the corresponding motors.

[0019] Compared with the prior art, the present invention has the following beneficial effects: The present invention, based on supercritical CO2 treatment, allows the drug components to be wrapped in soybean lecithin to form liposomes, so that they are hydrolyzed and released in the small intestine for absorption, thereby improving the absorption of the drug components in the human body. Furthermore, enteric materials are used to embed the drug components, so that the Chinese medicine pills do not dissolve in the stomach, but dissolve in the intestinal fluid, are not affected by gastric digestion, and are fully released in the small intestine, thereby improving the absorption of the Chinese medicine components in the human body and better exerting the efficacy.

[0020] In the process of pill making, the pill making area is kept dry, so that a certain drying effect is achieved to assist in the separation of pills and prevent blockage caused by material adhesion. Auxiliary powder is evenly sprinkled in and coated on the surface of the pills as an absorption layer during the pill making process, so that the ingredients of the pills are tightly bonded and not easy to disperse. While improving the pill effect, the absorbent can be replaced to ensure the medicinal properties of traditional Chinese medicine. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 Shown is a flow chart of the pill-making process of the combined Chinese medicine pills provided by the present invention.

[0022] Figure 2 Shown is a schematic structural diagram of a pill making device provided in Example 5 of the present invention.

[0023] Figure 3 Shown Figure 2 A partial plan perspective view of the .

[0024] Main component symbols 1. Shell; 2. Wet medicine block hopper; 3. Rotating assembly; 4. Screen; 5. Heating layer; 6. Powder sprinkling structure; 61. Bracket; 62. Powder container; 63. Press plate.

[0025] The above description of the main component symbols is combined with the accompanying drawings and specific implementation methods to further illustrate the present invention in detail. DETAILED DESCRIPTION

[0026] In order to make the purpose, technical scheme and advantages of the present invention clearer, the present invention is further described in detail below in conjunction with the embodiments. Additional aspects and advantages of the present invention will be given in part in the following description, and will become apparent from the following description, or will be understood through the practice of the present invention. It should be understood that the following description is only used to explain the present invention and is not intended to limit the present invention.

[0027] As used herein, the terms "comprises," "including," "contains," or any other variation thereof, are intended to cover a non-exclusive inclusion. For example, a composition, process, method, article, or apparatus that comprises the listed elements is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such composition, process, method, article, or apparatus.

[0028] When an amount, concentration, or other value or parameter is expressed as a range, a preferred range, or a range limited by a series of upper preferred values ​​and lower preferred values, this should be understood as specifically disclosing all ranges formed by any pairing of any range upper limit or preferred value with any range lower limit or preferred value, regardless of whether the range is disclosed separately. For example, when a range of "1 to 5" is disclosed, the described range should be interpreted as including a range of "1 to 4", "1 to 3", "1 to 2", "1 to 2 and 4 to 5", "1 to 3 and 5" etc. When a numerical range is described in this article, unless otherwise specified, the range is intended to include its end values ​​and all integers and fractions within the range.

[0029] The specific embodiments of the present invention are described in detail below.

[0030] Example 1 This embodiment provides a process for making a combined Chinese medicine pill, which comprises the following steps: S1 prepared Chinese medicinal materials (angelica, wolfberry, white peony root, atractylodes macrocephala, cornus officinalis, gardenia, ginseng, mint, and wolfberry) according to the prescription; S2 removes dirt impurities and non-medicinal parts of the Chinese medicinal materials, washes and dries the Chinese medicinal materials, and then crushes the Chinese medicinal materials to obtain Chinese medicinal materials. In this embodiment, the crushing process is based on the subsequent high-temperature cooking to facilitate the full separation of effective medicinal components.

[0031] After the S3 treatment, the Chinese medicinal materials are subjected to high-temperature cooking and then further concentrated and purified to obtain a mixed medicinal slurry. The high-temperature cooking is carried out in a reactor at a temperature of 80° C. and a cooking time of 12 hours.

[0032] The method for concentration and purification is specifically operated as follows: the boiled medicinal liquid and the medicinal residue are transferred to a concentrator for concentration and purification twice, and then the medicinal liquid is filtered to retain the medicinal liquid and the medicinal residue is discarded.

[0033] S4 processes soybean lecithin and mixed drug slurry based on supercritical CO2 method to obtain liposome drug solution; The method for obtaining the liposome drug solution is specifically operated as follows: S41 soybean lecithin and the mixed drug solution are taken in a ratio of 7:1, and the mixture is ground after mixing. S42 10 mL of PBS phosphate buffer solution with a concentration of 0.2 mol / L and a pH of 6.0 is added three times each time, and the grinding is continued evenly, and then transferred to an autoclave. S43 supercritical CO2 is introduced into the autoclave at a shear rate of 3000 r / min and a temperature of 45°C until the set pressure is turned on, the ultrasonic power is 18W, and the ultrasonic and shearing treatment is maintained for 50 minutes, and the heating, shearing and ultrasonic treatment are stopped in turn, and CO2 is released. S44 100 mL of PBS phosphate buffer solution is added to rinse the particles on the inner wall of the autoclave, and the ultrasonic and stirring treatment is carried out for 40 minutes to obtain a liposome drug solution.

[0034] In this embodiment, soybean lecithin and mixed drug slurry are processed based on supercritical CO2 method, so that the drug components are encapsulated in liposomes, which are hydrolyzed and released in the small intestine for absorption, thereby improving the absorption of the drug components in the human body.

[0035] S5 filters the liposome solution and retains the liposome particles.

[0036] S6: After deseeded hawthorn and honey are boiled, they are placed in a drying device and dried at 90° C. for 30 min. After the solid dry product is taken out, it is transferred to a grinder for grinding and pulverization to obtain a powdered auxiliary material for later use.

[0037] S7: 2 / 3 of the powdered excipients and liposome particles are mixed, and then talcum powder, excipients (water + rice paste) and CMC are added, and the mixture is stirred to obtain a wet drug block, wherein the talcum powder accounts for 0.5% of the total amount of the liposome particles, the excipients (water + rice paste) account for 6% of the total amount of the liposome particles, and the CMC accounts for 2% of the total amount of the liposome particles.

[0038] In this embodiment, talcum powder is added as an intermediate sand body, so that in the subsequent drying process, the medicine is evenly heated, the modification of the medicine components caused by uneven heat distribution is prevented, and the drying quality is improved. The added disintegrant promotes the disintegration and release of the traditional Chinese medicine components after the pills enter the human body, so that the medicinal properties are quickly dispersed, and the added excipients induce the viscosity of the medicine components to facilitate the pill molding.

[0039] S8 takes the wet medicine block and puts it into the pill making equipment, and then adds the remaining powdered auxiliary materials to make pills.

[0040] S9 performs jet embedding treatment on the pills obtained through the pill making treatment to obtain Chinese medicine pill products.

[0041] The method of spray embedding treatment is specifically operated as follows: cellulose acetate phthalate and water are taken in a volume ratio of 1:1, heated and ultrasonically stirred to obtain a solution. The solution is loaded into a spray device, and the size, speed and morphology of the piezoelectric nozzle droplets are controlled according to preset parameters, and the solution is evenly sprayed on the pills obtained by the pill making process, and then dried and polished to obtain the traditional Chinese medicine pill product.

[0042] In this embodiment, enteric-coated materials are used to embed the drug ingredients, so that the Chinese medicine pills do not dissolve in the stomach but dissolve in the intestinal fluid, are not affected by gastric digestion, and are fully released in the small intestine, thereby improving the absorption of the Chinese medicine ingredients in the human body and better exerting the efficacy.

[0043] Example 2 This embodiment provides a process for making a combined Chinese medicine pill, which comprises the following steps: S1 Prepare Chinese medicinal materials (wolfberry, rhubarb, astragalus, ginseng, asarum, cyathula, yam, white peony root and atractylodes) according to the prescription.

[0044] S2 removes dirt impurities and non-medicinal parts of the Chinese medicinal materials, washes and dries the Chinese medicinal materials, and then crushes the Chinese medicinal materials to obtain Chinese medicinal materials.

[0045] After the S3 treatment, the Chinese medicinal materials are subjected to high-temperature cooking and then further concentrated and purified to obtain a mixed medicinal slurry. The high-temperature cooking is carried out in a reactor at a temperature of 85° C. and a cooking time of 10 hours.

[0046] The method for concentration and purification is specifically operated as follows: the boiled medicinal liquid and the medicinal residue are transferred to a concentrator for concentration and purification three times, and then the medicinal liquid is filtered to retain the medicinal liquid and the medicinal residue is discarded.

[0047] S4 processes soybean lecithin and mixed drug slurry based on supercritical CO2 method to obtain liposome drug solution; The method for obtaining the liposome drug solution is specifically operated as follows: S41 soybean lecithin and the mixed drug solution are taken in a ratio of 7:1, and the mixture is ground after mixing. S42 10 mL of PBS phosphate buffer solution with a concentration of 0.2 mol / L and a pH of 6.0 is added three times each time, and the grinding is continued evenly, and then transferred to an autoclave. S43 supercritical CO2 is introduced into the autoclave at a shear rate of 3000 r / min and a temperature of 45°C until the set pressure is turned on, the ultrasonic power is 18W, and the ultrasonic and shearing treatment is maintained for 50 minutes, and the heating, shearing and ultrasonic treatment are stopped in turn, and CO2 is released. S44 100 mL of PBS phosphate buffer solution is added to rinse the particles on the inner wall of the autoclave, and the ultrasonic and stirring treatment is carried out for 40 minutes to obtain a liposome drug solution.

[0048] S5 filters the liposome solution and retains the liposome particles.

[0049] S6: After deseeded hawthorn and honey are boiled, they are placed in a drying device and dried at 95° C. for 25 min. After the solid dry product is taken out, it is transferred to a grinder for grinding and pulverization to obtain a powdered auxiliary material for later use.

[0050] S7: 2 / 3 of the powdered excipients are mixed with the liposome particles, and then talcum powder, excipients (wine + batter) and disintegrants are added, and the mixture is stirred to obtain a wet drug block, wherein the talcum powder accounts for 0.8% of the total amount of the liposome particles, the excipients (wine + batter) account for 8% of the total amount of the liposome particles, and the disintegrant accounts for 3% of the total amount of the liposome particles.

[0051] S8 takes the wet medicine block and puts it into the pill making equipment, and then adds the remaining powdered auxiliary materials to make pills.

[0052] S9 performs jet embedding treatment on the pills obtained through the pill making treatment to obtain Chinese medicine pill products.

[0053] The method of spray embedding treatment is specifically operated as follows: hydroxypropyl methylcellulose phthalate and water are taken in a volume ratio of 1:1, heated and ultrasonically stirred to obtain a solution. The solution is loaded into a spray device, and the size, speed and morphology of the piezoelectric nozzle droplets are controlled according to preset parameters, and the solution is evenly sprayed on the pills obtained by the pill making process, and then dried and polished to obtain the traditional Chinese medicine pill product.

[0054] Example 3 This embodiment provides a process for making a combined Chinese medicine pill, which comprises the following steps: S1 Prepare Chinese medicinal materials (angelica, wolfberry, rhubarb, ginseng, codonopsis, rehmannia root, atractylodes, julibrissin bark, and mint) according to the prescription.

[0055] S2 removes dirt impurities and non-medicinal parts of the Chinese medicinal materials, washes and dries the Chinese medicinal materials, and then crushes the Chinese medicinal materials to obtain Chinese medicinal materials.

[0056] After the S3 treatment, the Chinese medicinal materials are subjected to high-temperature cooking and then further concentrated and purified to obtain a mixed medicinal slurry. The high-temperature cooking is carried out in a reactor at a temperature of 95° C. and a cooking time of 10 hours.

[0057] The method for concentration and purification is specifically operated as follows: the boiled medicinal liquid and the medicinal residue are transferred to a concentrator for concentration and purification 4 times, and then the medicinal liquid is filtered to retain the medicinal residue and the medicinal residue is discarded.

[0058] S4 processes soybean lecithin and mixed drug slurry based on supercritical CO2 method to obtain liposome drug solution; The method for obtaining the liposome drug solution is specifically operated as follows: S41 soybean lecithin and the mixed drug solution are taken in a ratio of 7:1, and the mixture is ground after mixing. S42 10 mL of PBS phosphate buffer solution with a concentration of 0.2 mol / L and a pH of 6.0 is added three times each time, and the grinding is continued evenly, and then transferred to an autoclave. S43 supercritical CO2 is introduced into the autoclave at a shear rate of 3000 r / min and a temperature of 45°C until the set pressure is turned on, the ultrasonic power is 18W, and the ultrasonic and shearing treatment is maintained for 50 minutes, and the heating, shearing and ultrasonic treatment are stopped in turn, and CO2 is released. S44 100 mL of PBS phosphate buffer solution is added to rinse the particles on the inner wall of the autoclave, and the ultrasonic and stirring treatment is carried out for 40 minutes to obtain a liposome drug solution.

[0059] S5 filters the liposome solution and retains the liposome particles.

[0060] S6: After deseeded hawthorn and honey are boiled, they are placed in a drying device and dried at 95° C. for 25 min. After the solid dry product is taken out, it is transferred to a grinder for grinding and pulverization to obtain a powdered auxiliary material for later use.

[0061] S7: 2 / 3 of the powdered excipients are mixed with the liposome particles, and then talcum powder, excipients (vinegar + medicinal material paste) and HPMC are added, and the mixture is stirred to obtain a wet drug block, wherein the talcum powder accounts for 1.2% of the total amount of the liposome particles, the excipients (vinegar + medicinal material paste) account for 10% of the total amount of the liposome particles, and the HPMC accounts for 3% of the total amount of the liposome particles.

[0062] S8 takes the wet medicine block and puts it into the pill making equipment, and then adds the remaining powdered auxiliary materials to make pills.

[0063] S9 performs jet embedding treatment on the pills obtained through the pill making treatment to obtain Chinese medicine pill products.

[0064] The method of spray embedding treatment is specifically operated as follows: polyvinyl alcohol phthalate and water are taken in a volume ratio of 1:1, heated and ultrasonically stirred to obtain a solution. The solution is loaded into a spray device, and the size, speed and morphology of the piezoelectric nozzle droplets are controlled according to preset parameters, and the solution is evenly sprayed on the pills obtained by the pill making process, and then dried and polished to obtain the traditional Chinese medicine pill product.

[0065] Example 4 This embodiment provides a process for making a combined Chinese medicine pill, which comprises the following steps: S1 prepared Chinese medicinal materials (astragalus, ginseng, asarum, schisandra, codonopsis, rehmannia, mint, and wolfberry) according to the prescription.

[0066] S2 removes dirt impurities and non-medicinal parts of the Chinese medicinal materials, washes and dries the Chinese medicinal materials, and then crushes the Chinese medicinal materials to obtain Chinese medicinal materials.

[0067] After the S3 treatment, the Chinese medicinal materials are subjected to high-temperature cooking and then further concentrated and purified to obtain a mixed medicinal slurry. The high-temperature cooking is carried out in a reactor, and the temperature of the reactor is 100° C. and the cooking time is 6.

[0068] The method for concentration and purification is specifically operated as follows: the boiled medicinal liquid and the medicinal residue are transferred to a concentrator for concentration and purification for 5 times, and then the medicinal liquid is filtered to retain the medicinal residue and the medicinal residue is discarded.

[0069] S4 processes soybean lecithin and mixed drug slurry based on supercritical CO2 method to obtain liposome drug solution; The method for obtaining the liposome drug solution is specifically operated as follows: S41 soybean lecithin and the mixed drug solution are taken in a ratio of 7:1, and the mixture is ground after mixing. S42 10 mL of PBS phosphate buffer solution with a concentration of 0.2 mol / L and a pH of 6.0 is added three times each time, and the grinding is continued evenly, and then transferred to an autoclave. S43 supercritical CO2 is introduced into the autoclave at a shear rate of 3000 r / min and a temperature of 45°C until the set pressure is turned on, the ultrasonic power is 18W, and the ultrasonic and shearing treatment is maintained for 50 minutes, and the heating, shearing and ultrasonic treatment are stopped in turn, and CO2 is released. S44 100 mL of PBS phosphate buffer solution is added to rinse the particles on the inner wall of the autoclave, and the ultrasonic and stirring treatment is carried out for 40 minutes to obtain a liposome drug solution.

[0070] S5 filters the liposome solution and retains the liposome particles.

[0071] S6: After deseeded hawthorn and honey are boiled, they are placed in a drying device and dried at 100° C. for 20 minutes. After the solid dry product is taken out, it is transferred to a grinder for grinding and pulverization to obtain a powdered auxiliary material for later use.

[0072] S7: 2 / 3 of the powdered excipients are mixed with the liposome particles, and then talcum powder, excipients (medicine juice + rice paste) and HPMC are added, and the mixture is stirred to obtain a wet drug block, wherein the talcum powder accounts for 1.5% of the total amount of the liposome particles, the excipients (medicine juice + rice paste) account for 12% of the total amount of the liposome particles, and the HPMC accounts for 4% of the total amount of the liposome particles.

[0073] S8 takes the wet medicine block and puts it into the pill making equipment, and then adds the remaining powdered auxiliary materials to make pills.

[0074] S9 performs jet embedding treatment on the pills obtained through the pill making treatment to obtain Chinese medicine pill products.

[0075] The method of spray embedding treatment is specifically operated as follows: acrylic resin and water are taken in a volume ratio of 1:1, heated and ultrasonically stirred to obtain a solution. The solution is loaded into a spray device, and the size, speed and morphology of the piezoelectric nozzle droplets are controlled according to preset parameters, and the solution is evenly sprayed on the pills obtained by the pill making process, and then dried and polished to obtain the traditional Chinese medicine pill product.

[0076] Comparative Example 1 The difference between this comparative example and Example 1 is that: S4 to S5 are not performed, the mixed slurry is directly boiled, dried, and ground to obtain the medicine powder, and when S7 is performed, the powdered auxiliary material is mixed with the medicine powder. The rest is the same as Example 1.

[0077] Comparative Example 2 The difference between this comparative example and Example 1 is that S9 is not performed. The rest is the same as Example 1.

[0078] In the pill making process of Example 1 and Comparative Examples 1-2, the selected Chinese medicinal materials include angelica, wolfberry, white peony root, ginseng, etc., which have the effects of nourishing the liver and kidney, replenishing yin and blood, and clearing away heat. The prepared Chinese medicine pill preparations are suitable for symptoms such as liver and kidney deficiency, yin deficiency and blood deficiency.

[0079] The Chinese medicine pills prepared in Example 1 and Comparative Examples 1-2 were made into pill preparations and subjected to human trials and evaluations.

[0080] According to the 2002 edition of the Guiding Principles for Clinical Research of New Chinese Medicines, during the recruitment of research subjects, those who met two main symptoms and two secondary symptoms were diagnosed with liver and kidney deficiency and yin deficiency and blood deficiency and were included in the study. The main symptoms were pale complexion, fatigue, insomnia, palpitations and shortness of breath; the secondary symptoms were dizziness, fever in the five hearts and insomnia.

[0081] The subjects were divided into three groups (respectively taking the pill preparations of Example 1 and Comparative Examples 1-2), each group of 30 people, and the subjects completed the TCM symptom scoring form and received the treatment of oral pill preparations. The main symptoms and secondary symptoms of the three groups of subjects before and after treatment were scored to obtain symptom scores, and then the clinical efficacy of the subjects was analyzed and judged based on the symptom scores. Each symptom was scored as 0, 1, 2, and 3 points according to the levels of none, mild, moderate, and severe; and the scores of each item were added together to obtain the symptom score.

[0082] According to the "Guidelines for Clinical Research of New Chinese Medicines", clinical efficacy is divided into the following four levels: Recovery: Symptom score reduction is greater than or equal to 95%, and TCM clinical symptoms and signs are completely relieved or disappear; Markedly effective: The symptom score is reduced by 70% or more, and the clinical symptoms and signs of traditional Chinese medicine are significantly improved; Effective: The symptom score is reduced by 30% or more, and both clinical symptoms and signs of TCM show signs of improvement; Ineffective: The symptom score decreases by less than or equal to 30%, and the TCM clinical symptoms and signs do not improve, or even show signs of worsening.

[0083] The number of subjects who were cured, significantly effective, effective and ineffective was obtained, and the total effective number and total effective rate were calculated and recorded in Table 1; among which, the total effective number = the number of cured cases + the number of significantly effective cases + the number of effective cases, and the total effective rate = (the number of cured cases + the number of significantly effective cases + the number of effective cases) / the total number of cases × 100%.

[0084] Table 1 Clinical efficacy analysis of pill preparations

[0085] As shown in Table 1, after the subjects took the above three products for 1 month, their symptoms were relieved to varying degrees. The symptoms were scored, and the effective rate of improving the symptoms of the volunteers by taking the pill preparation of Example 1 was 86.7%, while the effective rate of improving the symptoms of the volunteers by taking the pill preparation of Comparative Example 1 was 40%, and the effective rate of improving the symptoms of the volunteers by taking the pill preparation of Comparative Example 2 was 50%. The reason for such significant differences is that the pill preparations of Comparative Examples 1 and 2 were not embedded and lipidated during preparation, resulting in their efficacy being affected by gastric acid and not being well exerted.

[0086] Example 5 See also Figure 2-3 This embodiment provides a pill making device, which is applied to the pill making process of any combination of Chinese medicine pills in embodiments 1 to 4. The pill making device includes a housing 1, a wet medicine block inlet hopper 2 fixedly installed through the center of the top of the housing 1, a rotating assembly 3 rotatably installed in the housing 1, a screen 4 fixedly installed at the discharge port of the housing 1, a heating layer 5 fixedly installed in the housing 1, and a powder sprinkling structure 6 fixedly installed at the top surface of the wet medicine block inlet hopper 2.

[0087] The powder sprinkling structure 6 includes a bracket 61, a powder holding barrel 62 that is slidably installed at the center of the bracket 61, and a pressure plate 63 that is fixedly sleeved on the powder holding barrel 62. The powder holding barrel 62 is located above the wet medicine block inlet 2, and a mesh cover is welded to the bottom of the powder holding barrel 62; the lower surface of the pressure plate 63 is in contact with the upper surface of the bracket 61. In this embodiment, by applying a rotational force to the powder holding barrel 62, the powdered auxiliary materials in the barrel are evenly sprinkled into the pill making area, and the sprinkled auxiliary materials are coated on the surface of the pills as an absorption layer, so that the ingredients of the pills are tightly bonded and not easy to disperse, which improves the pill making effect and can replace the absorbent to ensure the medicinal properties of traditional Chinese medicine. The bracket 61 provides placement and rotation support for the powder holding barrel 62, and combines with the pressure plate 63 to provide rotation limit to prevent the powder holding barrel 62 from falling out.

[0088] The rotating assembly 3 includes two groups of motors fixedly mounted at the front surface of the housing 1 and pill-making rollers fixedly connected at the output ends of the corresponding motors. The two groups of pill-making rollers are arranged horizontally in the housing 1, and the pill-making rollers are located below the wet medicine block inlet 2. In this embodiment, the wet medicine block is fed into the housing 1 through the wet medicine block inlet 2, and the rotating assembly 3 is running. The medicine is formed under the action of the pill-making rollers in a rotating state, and the formed pill-shaped particles are output along the discharge port through the screen 4.

[0089] The heating layer 5 is arranged around the outside of the rotating assembly 3, and a resistance wire is filled in the heating layer 5. During the pelletizing process, the heating layer 5 heats the pelletizing area to increase the dryness of the particles, thereby preventing the particles from sticking and agglomerating.

[0090] The pill making equipment of this embodiment has the following advantages: during the pill making process, the pill making area can be kept dry, so that it has a certain drying effect to assist in the separation of the pills and prevent blockage caused by material adhesion. Auxiliary powder is evenly sprinkled in and coated on the surface of the pills as an absorption layer during the pill making process, so that the pill ingredients are tightly bonded and not easy to disperse. While improving the pill effect, it can replace the absorbent to ensure the medicinal properties of traditional Chinese medicine.

[0091] The above embodiments are merely preferred implementations of the present invention. Any simple modification, amendment and substitution of the above embodiments based on the technical essence of the present invention shall fall within the scope of the technical solution of the present invention.

Claims

1. A process for making a combined Chinese medicine pill, characterized in that: The steps include: S1 Prepare Chinese medicinal materials according to prescriptions; S2 processes Chinese medicinal materials; After the Chinese medicinal materials treated in S3 are boiled at high temperature, they are further concentrated and purified to obtain a mixed medicinal slurry; S4 processes soybean lecithin and mixed drug slurry based on supercritical CO2 method to obtain liposome drug solution; S5 filters the liposome solution and retains the liposome particles; S6: Boil the seeded hawthorn and honey, dry them to obtain a powdered auxiliary material, and set aside; S7: 2 / 3 of the powdered excipients and liposome particles are mixed, and then talcum powder, excipients and disintegrants are added, and the mixture is stirred to obtain a wet drug block; S8 takes the wet medicine block and puts it into the pill making equipment, and then adds the remaining powdered auxiliary materials to make pills; S9 performs jet embedding treatment on the pills obtained through the pill making treatment to obtain Chinese medicine pill products.

2. The process for making the combined Chinese medicine pills according to claim 1, characterized in that: The Chinese medicinal materials include at least eight of angelica, wolfberry, rhubarb, astragalus, ginseng, asarum, schisandra, codonopsis, rehmannia, achyranthes, yam, white peony root, atractylodes, cornus officinalis, gardenia, julibrissin bark, mint and wolfberry.

3. The process for making the combined Chinese medicine pills according to claim 1, characterized in that: The specific operation of the method for processing Chinese medicinal materials is as follows: removing soil impurities and non-medicinal parts of the Chinese medicinal materials, washing and drying the Chinese medicinal materials, and then crushing the Chinese medicinal materials to obtain the Chinese medicinal materials.

4. The process for making the combined Chinese medicine pills according to claim 1, characterized in that: The high temperature cooking is carried out in a reactor, and the temperature of the reactor is 80-100° C., and the cooking time is 6-12 hours; The method for concentration and purification is specifically operated as follows: the boiled medicinal liquid and the medicinal residue are transferred to a concentrator for concentration and purification 2 to 5 times, and then the medicinal liquid is filtered to retain the medicinal residue and the medicinal residue is discarded; the concentration and purification adopts any one of water decoction, immersion, percolation, modified gelatin method, reflux method, solvent extraction, steam distillation and sublimation.

5. The process for making the combined Chinese medicine pills according to claim 1, characterized in that: The method for obtaining the liposome liquid medicine is specifically performed as follows: S41 Take soybean lecithin and mixed medicine slurry in a ratio of 7:1, mix and grind; S42 was added three times, 10 mL of 0.2 mol / L PBS phosphate buffer solution with a pH of 6.0 was added each time, and the mixture was further ground evenly, and then transferred to an autoclave; S43: At a shear rate of 3000 r / min and a temperature of 45°C, supercritical CO2 was introduced into the autoclave until the set pressure was reached, and then ultrasound was turned on with an ultrasound power of 18 W. The ultrasound and shearing treatment was maintained for 50 min, and the heating, shearing and ultrasound were stopped in sequence, and CO2 was released; S44 added 100 mL of PBS phosphate buffer solution to rinse the particles on the inner wall of the autoclave, and treated with ultrasound and stirring for 40 minutes to obtain a liposome drug solution.

6. The process for making the combined Chinese medicine pills according to claim 1, characterized in that: The seeded hawthorn and honey are boiled and placed in a drying device, and dried at a temperature of 90-100° C. for 20-30 minutes. The solid dry product is taken out and transferred to a grinder for grinding and pulverization to obtain a powdered auxiliary material.

7. The process for making the combined Chinese medicine pills according to claim 1, characterized in that: The talc accounts for 0.5% to 1.5% of the total amount of the liposome particles, the excipient accounts for 6% to 12% of the total amount of the liposome particles, and the disintegrant accounts for 2% to 4% of the total amount of the liposome particles; The disintegrant is CMC or HPMC, which is used to promote the disintegration and release of the traditional Chinese medicine pills after entering the human body; the excipients include a wetting agent and a binder; wherein the wetting agent is water, wine, vinegar or medicinal juice, and the binder is rice paste, flour paste or medicinal material paste.

8. The process for making the combined Chinese medicine pills according to claim 7, characterized in that: The method of spray embedding treatment is specifically performed as follows: S91: taking an enteric material and water in a volume ratio of 1:1, heating and ultrasonically stirring to obtain a solution; The S92 solution is loaded into the spraying device, and the size, speed and morphology of the piezoelectric nozzle droplets are controlled according to the preset parameters. The solution is evenly sprayed on the pills obtained through the pill making process, and then dried and polished to obtain the Chinese medicine pill products.

9. The process for making the combined Chinese medicine pills according to claim 1, characterized in that: The pill making equipment comprises a shell, a wet medicine block inlet hopper fixedly installed through the center of the top of the shell, a rotating assembly rotatably installed in the shell, a screen fixedly installed at the discharge port of the shell, a heating layer fixedly installed in the shell, and a powder sprinkling structure fixedly installed at the top surface of the wet medicine block inlet hopper.

10. The process for making the combined Chinese medicine pills according to claim 9, characterized in that: The powder sprinkling structure comprises a bracket, a powder holding tube slidably installed at the center of the bracket, and a pressure plate fixedly sleeved on the powder holding tube; The rotating assembly comprises two groups of motors fixedly mounted at the front surface of the shell and a pill-making roller fixedly connected at the output end of the corresponding motor.

Citation Information

Patent Citations

  • Traditional Chinese medicine compound health-care medicinal pill and preparation method thereof

    CN111529595A

  • Traditional Chinese medicine pill for treating endocrine dyscrasia in cooperation with acupuncture and preparation process thereof

    CN110974889A

  • Peptide-containing composition for improving immunity of human body and preparation method of peptide-containing composition

    CN119564822A

  • Rheumatic arthritis treatment traditional Chinese medicine containing embelia parviflora and preparation method of rheumatic arthritis treatment traditional Chinese medicine

    CN119818589A

  • Medicinal automatic pill making machine

    CN203576943U